Trump Administration Expands Fertility Treatment Coverage
The Trump administration has announced a deal with EMD Serono to lower drug prices, aiming to expand coverage and improve affordability for fertility services.
- Lowering drug prices through a deal with EMD Serono
- New benefits rules to encourage employers to offer in vitro fertilization coverage
- A Food and Drug Administration priority review voucher for another fertility drug
These components are part of a larger push to improve fertility services, officials announced at the White House.
No specific quotes available in the given text.
Author's summary: Trump administration expands fertility treatment coverage with new deal.